1. C. G. Cochrane, S. D. Revak, B. S. Aiken, and K. D. Wuepper, The structural characteristics and activation of Hageman factor, in: “Inflammation: Mechanisms and Control,” I. H. Lepow and P. A. Ward, eds., Academic Press, New York (1972).
2. J. E. Sealey, S. A. Atlas, J. H. Laragh, N. B. Oza, and J. W. Ryan, Human urinary kallikrein converts inactive renin to active renin and is a possible physiologic activator of renin. Nature, 275: 144 (1978).
3. O. ole-MoiYoi, D. C. Seldin, J. Spragg, G. S. Pinkus, and K.F. Austen, Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc, Natl. Acad. Sci. (USA), 76: 3612 (1979).
4. M. G. Currie, D. M. Geller, J. Chao, H. S. Margolius, and P. Needleman, Kallikrein activation of a high molecular weight atrial peptide. Biochem. Biophys. Res. Comm., 120: 461 (1984).
5. E. S. Prado, L. Prado de Carvalho, M. S. Araujo-Viel, N. Ling, and J. Rossier, A met-enkephalin-containing peptide, BAM 22P, as a novel substrate for glandular kallikrein. Biochem. Biophys.Res. Comm., 112: 366 (1983).